Tirzepatide trials report similar tolerability, with 4-8% discontinuation due to adverse events, predominantly gastrointestinal
ScienceDirect , European Journal of Gastroenterology & Hepatology , vol
Always consult a licensed healthcare provider before starting or changing any weight loss treatment plan
Your doctor should assess several factors before approving discontinuation, including your current weight status and trajectory, the presence and control of obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), your readiness and capacity to implement intensive lifestyle modifications, available support systems and resources, and your history of weight cycling or previous weight loss attempts
B12 is often added to support normal energy metabolism
Overall wellness and recovery